Global Activated Clotting Time Testing Market Research Report 2024

Publication ID:

PB505248835

Publication Date:

May 6, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The activated clotting time (ACT) is a test that is used primarily to monitor high doses of unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given intravenously (IV) by injection or continuous infusion. High doses of heparin may be given during procedures that require that blood be prevented from clotting, such as heart bypass surgery.
The global Activated Clotting Time Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Activated Clotting Time Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Activated Clotting Time Testing.
Report Scope
The Activated Clotting Time Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Activated Clotting Time Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Activated Clotting Time Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp
Segment by Type
Optical Detection
Laser-based Detection
Mechanical Detection
Fluorescent Based Detection
Segment by Application
Hospitals
Clinical Laboratories
Ambulatory Surgical Center
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Activated Clotting Time Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Activated Clotting Time Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Optical Detection
1.2.3 Laser-based Detection
1.2.4 Mechanical Detection
1.2.5 Fluorescent Based Detection
1.3 Market by Application
1.3.1 Global Activated Clotting Time Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Ambulatory Surgical Center
1.3.5 Academic & Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Activated Clotting Time Testing Market Perspective (2019-2030)
2.2 Activated Clotting Time Testing Growth Trends by Region
2.2.1 Global Activated Clotting Time Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Activated Clotting Time Testing Historic Market Size by Region (2019-2024)
2.2.3 Activated Clotting Time Testing Forecasted Market Size by Region (2025-2030)
2.3 Activated Clotting Time Testing Market Dynamics
2.3.1 Activated Clotting Time Testing Industry Trends
2.3.2 Activated Clotting Time Testing Market Drivers
2.3.3 Activated Clotting Time Testing Market Challenges
2.3.4 Activated Clotting Time Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Activated Clotting Time Testing Players by Revenue
3.1.1 Global Top Activated Clotting Time Testing Players by Revenue (2019-2024)
3.1.2 Global Activated Clotting Time Testing Revenue Market Share by Players (2019-2024)
3.2 Global Activated Clotting Time Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Activated Clotting Time Testing Revenue
3.4 Global Activated Clotting Time Testing Market Concentration Ratio
3.4.1 Global Activated Clotting Time Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Activated Clotting Time Testing Revenue in 2023
3.5 Activated Clotting Time Testing Key Players Head office and Area Served
3.6 Key Players Activated Clotting Time Testing Product Solution and Service
3.7 Date of Enter into Activated Clotting Time Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Activated Clotting Time Testing Breakdown Data by Type
4.1 Global Activated Clotting Time Testing Historic Market Size by Type (2019-2024)
4.2 Global Activated Clotting Time Testing Forecasted Market Size by Type (2025-2030)
5 Activated Clotting Time Testing Breakdown Data by Application
5.1 Global Activated Clotting Time Testing Historic Market Size by Application (2019-2024)
5.2 Global Activated Clotting Time Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Activated Clotting Time Testing Market Size (2019-2030)
6.2 North America Activated Clotting Time Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Activated Clotting Time Testing Market Size by Country (2019-2024)
6.4 North America Activated Clotting Time Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Activated Clotting Time Testing Market Size (2019-2030)
7.2 Europe Activated Clotting Time Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Activated Clotting Time Testing Market Size by Country (2019-2024)
7.4 Europe Activated Clotting Time Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Activated Clotting Time Testing Market Size (2019-2030)
8.2 Asia-Pacific Activated Clotting Time Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Activated Clotting Time Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Activated Clotting Time Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Activated Clotting Time Testing Market Size (2019-2030)
9.2 Latin America Activated Clotting Time Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Activated Clotting Time Testing Market Size by Country (2019-2024)
9.4 Latin America Activated Clotting Time Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Activated Clotting Time Testing Market Size (2019-2030)
10.2 Middle East & Africa Activated Clotting Time Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Activated Clotting Time Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Activated Clotting Time Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Activated Clotting Time Testing Introduction
11.1.4 Roche Revenue in Activated Clotting Time Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Activated Clotting Time Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Activated Clotting Time Testing Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Activated Clotting Time Testing Introduction
11.3.4 Abbott Revenue in Activated Clotting Time Testing Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Helena Laboratories
11.4.1 Helena Laboratories Company Detail
11.4.2 Helena Laboratories Business Overview
11.4.3 Helena Laboratories Activated Clotting Time Testing Introduction
11.4.4 Helena Laboratories Revenue in Activated Clotting Time Testing Business (2019-2024)
11.4.5 Helena Laboratories Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Activated Clotting Time Testing Introduction
11.5.4 Sysmex Revenue in Activated Clotting Time Testing Business (2019-2024)
11.5.5 Sysmex Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Detail
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Activated Clotting Time Testing Introduction
11.6.4 Medtronic Revenue in Activated Clotting Time Testing Business (2019-2024)
11.6.5 Medtronic Recent Development
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Detail
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Activated Clotting Time Testing Introduction
11.7.4 Instrumentation Laboratory Revenue in Activated Clotting Time Testing Business (2019-2024)
11.7.5 Instrumentation Laboratory Recent Development
11.8 Diagnostica Stago
11.8.1 Diagnostica Stago Company Detail
11.8.2 Diagnostica Stago Business Overview
11.8.3 Diagnostica Stago Activated Clotting Time Testing Introduction
11.8.4 Diagnostica Stago Revenue in Activated Clotting Time Testing Business (2019-2024)
11.8.5 Diagnostica Stago Recent Development
11.9 Werfen
11.9.1 Werfen Company Detail
11.9.2 Werfen Business Overview
11.9.3 Werfen Activated Clotting Time Testing Introduction
11.9.4 Werfen Revenue in Activated Clotting Time Testing Business (2019-2024)
11.9.5 Werfen Recent Development
11.10 LabCorp
11.10.1 LabCorp Company Detail
11.10.2 LabCorp Business Overview
11.10.3 LabCorp Activated Clotting Time Testing Introduction
11.10.4 LabCorp Revenue in Activated Clotting Time Testing Business (2019-2024)
11.10.5 LabCorp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Roche
Thermo Fisher Scientific
Abbott
Helena Laboratories
Sysmex
Medtronic
Instrumentation Laboratory
Diagnostica Stago
Werfen
LabCorp

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂